Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Mockus

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Expert Review of Molecular Diagnostics|April 13, 2017
Barriers preventing the adoption of comprehensive cancer genomic profiling in the clinicCara M Statz, Sara E Patterson, Susan M Mockus
Targeted Oncology|August 10, 2016
mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic ReviewCara M Statz, Sara E Patterson, Susan M Mockus
NPJ Precision Oncology|January 25, 2019
Utility of the JAX Clinical Knowledgebase in capture and assessment of complex genomic cancer dataSara E Patterson, Cara M Statz, Taofei Yin, et al.
Clinical Chemistry|November 27, 2015
Clinical Trials in Precision OncologySusan M Mockus, Sara E Patterson, Cara Statz, et al.
Human Genomics|January 17, 2016
The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapiesSara E Patterson, Rangjiao Liu, Cara M Statz, et al.
Molecular and Cellular Neurosciences|December 21, 2004
Mechanism of SNARE protein binding and regulation of Cav2 channels by phosphorylation of the synaptic protein interaction siteCharles T Yokoyama, Scott J Myers, Jian Fu, et al.
Analytical Chemistry|June 30, 2023
Assessment of a 60-Biomarker Health Surveillance Panel (HSP) on Whole Blood from Remote Sampling Devices by Targeted LC/MRM-MS and Discovery DIA-MS AnalysisStephen A Whelan, Nathan Hendricks, Zachary L Dwight, et al.
The American Journal of Pathology|January 23, 2016
Molecular Genetic Analysis of Ovarian Brenner Tumors and Associated Mucinous Epithelial Neoplasms: High Variant Concordance and Identification of Mutually Exclusive RAS Driver Mutations and MYC AmplificationLaura J Tafe, Kristen E Muller, Guruprasad Ananda, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomesPaul A VanderLaan, Deepa Rangachari, Susan M Mockus, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
New Gain-of-Function Mutations Prioritize Mechanisms of HER2 ActivationChristopher J Giacoletto, Liz J Valente, Lancer Brown, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Review of Molecular Diagnostics|April 13, 2017
Barriers preventing the adoption of comprehensive cancer genomic profiling in the clinicCara M Statz, Sara E Patterson, Susan M Mockus
Targeted Oncology|August 10, 2016
mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic ReviewCara M Statz, Sara E Patterson, Susan M Mockus
NPJ Precision Oncology|January 25, 2019
Utility of the JAX Clinical Knowledgebase in capture and assessment of complex genomic cancer dataSara E Patterson, Cara M Statz, Taofei Yin, et al.
Clinical Chemistry|November 27, 2015
Clinical Trials in Precision OncologySusan M Mockus, Sara E Patterson, Cara Statz, et al.
Human Genomics|January 17, 2016
The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapiesSara E Patterson, Rangjiao Liu, Cara M Statz, et al.
Molecular and Cellular Neurosciences|December 21, 2004
Mechanism of SNARE protein binding and regulation of Cav2 channels by phosphorylation of the synaptic protein interaction siteCharles T Yokoyama, Scott J Myers, Jian Fu, et al.
Analytical Chemistry|June 30, 2023
Assessment of a 60-Biomarker Health Surveillance Panel (HSP) on Whole Blood from Remote Sampling Devices by Targeted LC/MRM-MS and Discovery DIA-MS AnalysisStephen A Whelan, Nathan Hendricks, Zachary L Dwight, et al.
The American Journal of Pathology|January 23, 2016
Molecular Genetic Analysis of Ovarian Brenner Tumors and Associated Mucinous Epithelial Neoplasms: High Variant Concordance and Identification of Mutually Exclusive RAS Driver Mutations and MYC AmplificationLaura J Tafe, Kristen E Muller, Guruprasad Ananda, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
Mutations in TP53, PIK3CA, PTEN and other genes in EGFR mutated lung cancers: Correlation with clinical outcomesPaul A VanderLaan, Deepa Rangachari, Susan M Mockus, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
New Gain-of-Function Mutations Prioritize Mechanisms of HER2 ActivationChristopher J Giacoletto, Liz J Valente, Lancer Brown, et al.
Pageof 2